{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:47:25Z","timestamp":1793141245408,"version":"4.5.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Subclinical myocardial injury (SMI) represents an early, asymptomatic stage of cardiac damage characterized by elevated high-sensitivity cardiac troponin T (hs-cTnT) levels in the absence of overt ischemia. Glycemic variability has been increasingly recognized as a cardiovascular risk factor beyond chronic hyperglycemia, but its relationship with SMI in type 2 diabetes mellitus (T2DM) remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cross-sectional analysis included 324 hospitalized patients with T2DM consecutively admitted between January 2021 and December 2023 at a tertiary hospital in Southwest China. SMI was defined as hs-cTnT &amp;gt; 14 ng\/L without ischemic symptoms or electrocardiographic abnormalities. Clinical, metabolic, and laboratory data were extracted from electronic medical records. Short-term (in-hospital) glycemic variability was quantified using the standard deviation (SD) and coefficient of variation (CV) of all capillary glucose measurements obtained during hospitalization. Univariate and multivariate logistic regression analyses identified independent predictors of SMI. Model discrimination, calibration, and nomogram-based prediction were evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 324 patients, 128 (39.5%) exhibited SMI. In multivariate analysis, eight variables were independently associated with SMI: age (OR = 1.05,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.001), BMI (OR = 1.10,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.006), diabetes duration (OR = 1.06,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.004), insulin use (OR = 1.72,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.015), SD of glucose (OR = 3.11,\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001), systolic blood pressure (OR = 1.02,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.038), hs-CRP (OR = 1.08,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.009), and eGFR (OR = 0.97,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.003). The predictive model showed good discrimination (AUC = 0.832, 95% CI 0.787\u20130.877) and good calibration (Hosmer\u2013Lemeshow\n                      <jats:italic>P<\/jats:italic>\n                      = 0.47). A nomogram based on these predictors provided individualized risk estimation with high clinical interpretability.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Short-term (in-hospital) glycemic variability, as reflected by the standard deviation of inpatient glucose readings, was independently associated with subclinical myocardial injury in hospitalized patients with type 2 diabetes. These findings suggest that glycemic variability may serve as a risk marker for subclinical myocardial injury in hospitalized patients with T2DM; however, causal relationships and temporal ordering cannot be inferred from this cross-sectional analysis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1725076","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T06:56:56Z","timestamp":1770706616000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Association of short-term glycemic variability with subclinical myocardial injury in hospitalized patients with type 2 diabetes: a retrospective cross-sectional study"],"prefix":"10.3389","volume":"13","author":[{"given":"Ling","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu","place":["Sichuan, China"]},{"name":"West China School of Nursing, Sichuan University, Chengdu","place":["Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu","place":["Sichuan, China"]},{"name":"West China School of Nursing, Sichuan University, Chengdu","place":["Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangli","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu","place":["Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"98","DOI":"10.2174\/0115733998277127231211063107","article-title":"Progress in cardiac magnetic resonance feature tracking for evaluating myocardial strain in type-2 diabetes mellitus.","volume":"20","author":"Shen","year":"2024","journal-title":"Curr Diabetes Rev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e83925","DOI":"10.7759\/cureus.83925","article-title":"Prognostic value of high-sensitivity troponin in predicting long-term cardiovascular outcomes in patients with type 2 diabetes: a systematic review.","volume":"17","author":"Shahid","year":"2025","journal-title":"Cureus."},{"key":"B3","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41569-023-00877-z","article-title":"Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention.","volume":"20","author":"Wong","year":"2023","journal-title":"Nat Rev Cardiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12933-024-02307-x","article-title":"Assessment of subclinical LV myocardial dysfunction in T2DM patients with diabetic peripheral neuropathy: a cardiovascular magnetic resonance study.","volume":"23","author":"Li","year":"2024","journal-title":"Cardiovasc Diabetol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.3390\/biomedicines12092031","article-title":"Subclinical left ventricular dysfunction over seven-year follow-up in type 2 diabetes patients without cardiovascular diseases.","volume":"12","author":"Akasheva","year":"2024","journal-title":"Biomedicines."},{"key":"B6","doi-asserted-by":"publisher","first-page":"464","DOI":"10.2337\/dc24-0654","article-title":"Diabetes, subclinical myocardial injury or stress, and risk of heart failure subtypes: the jackson heart study.","volume":"48","author":"Kaze","year":"2025","journal-title":"Diabetes Care."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1350573","DOI":"10.3389\/fcvm.2024.1350573","article-title":"Preclinical screening for cardiovascular disease with high-sensitivity cardiac troponins: ready, set, go?","volume":"11","author":"Awwad","year":"2024","journal-title":"Front Cardiovasc Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1059303","DOI":"10.3389\/fendo.2023.1059303","article-title":"Association between diabetes status and breast cancer in US adults: findings from the US National health and nutrition examination survey.","volume":"14","author":"Sun","year":"2023","journal-title":"Front Endocrinol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3390\/biom15020188","article-title":"A narrative review: relationship between glycemic variability and emerging complications of diabetes mellitus.","volume":"15","author":"Wang","year":"2025","journal-title":"Biomolecules."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.3390\/jcm14072434","article-title":"Glycemic variability and its association with traditional glycemic control biomarkers in patients with type 1 diabetes: a cross-sectional.","volume":"14","author":"Lazar","year":"2025","journal-title":"Multicenter Study. J Clin Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/jdi.14112","article-title":"Glycemic variability: measurement, target, impact on complications of diabetes and does it really matter?","volume":"15","author":"Mo","year":"2024","journal-title":"J Diabetes Investig."},{"key":"B12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12933-023-02092-z","article-title":"Distribution and prognostic value of high-sensitivity cardiac troponin T and I across glycemic status: a population-based study.","volume":"23","author":"Zhang","year":"2024","journal-title":"Cardiovasc Diabetol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"101894","DOI":"10.1016\/j.jacadv.2025.101894","article-title":"Subclinical myocardial injury and global cognitive performance: MESA (Multi-ethnic study of atherosclerosis).","volume":"4","author":"Tomar","year":"2025","journal-title":"JACC Adv."},{"key":"B14","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3390\/antiox11020336","article-title":"The role of oxidative stress in the aging heart.","volume":"11","author":"Pagan","year":"2022","journal-title":"Antioxidants."},{"key":"B15","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1161\/CIRCRESAHA.119.312321","article-title":"Obesity, hypertension, and cardiac dysfunction: novel roles of immunometabolism in macrophage activation and inflammation.","volume":"126","author":"Mouton","year":"2020","journal-title":"Circ Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1161\/ATVBAHA.113.300156","article-title":"Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis.","volume":"34","author":"Messner","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e037332","DOI":"10.1161\/JAHA.124.037332","article-title":"Association of coronary microvascular rarefaction and myocardial fibrosis with coronary artery disease.","volume":"13","author":"Campbell","year":"2024","journal-title":"J Am Heart Assoc."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.120.315913","article-title":"Basic mechanisms of diabetic heart disease.","volume":"126","author":"Ritchie","year":"2020","journal-title":"Circ Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.2147\/CIA.S528020","article-title":"Risk factors of subclinical left ventricular systolic dysfunction in older adults with type 2 diabetes and preserved LVEF.","volume":"20","author":"Yang","year":"2025","journal-title":"Clin Interv Aging."},{"key":"B20","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s13098-023-01180-0","article-title":"Assessment of subclinical left ventricular myocardial systolic dysfunction in type 2 diabetes mellitus patients with or without hypertension by global and segmental myocardial work.","volume":"15","author":"Li","year":"2023","journal-title":"Diabetol Metab Syndr."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.3390\/jcm14082833","article-title":"Cardiovascular-kidney-metabolic syndrome: a new paradigm in clinical medicine or going back to basics?","volume":"14","author":"Mutruc","year":"2025","journal-title":"J Clin Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"599545","DOI":"10.3389\/fcvm.2021.599545","article-title":"Insulin therapy is associated with an increased risk of carotid plaque in type 2 diabetes: a real-world study.","volume":"8","author":"Ke","year":"2021","journal-title":"Front Cardiovasc Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.7150\/ijms.61891","article-title":"Effects of renal impairment on cardiac remodeling and clinical outcomes after myocardial infarction.","volume":"18","author":"Chiang","year":"2021","journal-title":"Int J Med Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.3390\/ijms25052973","article-title":"New insights into endothelial dysfunction in cardiometabolic diseases: potential mechanisms and clinical implications.","volume":"25","author":"Gallo","year":"2024","journal-title":"Int J Mol Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s12933-024-02356-2","article-title":"A high-volume study on the impact of diabetes mellitus on clinical outcomes after surgical and percutaneous cardiac interventions.","volume":"23","author":"Slingerland","year":"2024","journal-title":"Cardiovasc Diabetol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"110644","DOI":"10.1016\/j.diabres.2023.110644","article-title":"Glycaemic control in people with diabetes following acute myocardial infarction.","volume":"199","author":"Esdaile","year":"2023","journal-title":"Diabetes Res Clin Pract."},{"key":"B27","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3390\/biology14040438","article-title":"Battle of the biomarkers of systemic inflammation.","volume":"14","author":"Stec-Martyna","year":"2025","journal-title":"Biology."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1323571","DOI":"10.3389\/fendo.2024.1323571","article-title":"Glycemic variability evaluated by HbA1c rather than fasting plasma glucose is associated with adverse cardiovascular events.","volume":"15","author":"Sheng","year":"2024","journal-title":"Front Endocrinol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"20909","DOI":"10.1038\/s41598-024-71904-3","article-title":"Development and validation of nomograms for predicting cardiovascular disease risk in patients with prediabetes and diabetes.","volume":"14","author":"Li","year":"2024","journal-title":"Sci Rep."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1641114","DOI":"10.3389\/fendo.2025.1641114","article-title":"Predicting diabetic cardiomyopathy in type 2 diabetes: development and validation of a nomogram based on clinical and echocardiographic parameters.","volume":"16","author":"Luo","year":"2025","journal-title":"Front Endocrinol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1159\/000538361","article-title":"Metabolic syndrome and cardiac vessel remodeling associated with vessel rarefaction: a possible underlying mechanism may result from a poor angiogenic response to altered VEGF signaling pathways.","volume":"61","author":"Bartkowiak","year":"2024","journal-title":"J Vasc Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1161\/CIRCRESAHA.124.325488","article-title":"Renal-cardiac crosstalk in the pathogenesis and progression of heart failure.","volume":"136","author":"Noels","year":"2025","journal-title":"Circ Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.4239\/wjd.v12.i7.1070","article-title":"Multi-omics: opportunities for research on mechanism of type 2 diabetes mellitus.","volume":"12","author":"Wang","year":"2021","journal-title":"World J Diabetes."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1196293","DOI":"10.3389\/fendo.2023.1196293","article-title":"The oxidative aging model integrated various risk factors in type 2 diabetes mellitus at system level.","volume":"14","author":"Chen","year":"2023","journal-title":"Front Endocrinol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1725076\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T06:56:57Z","timestamp":1770706617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1725076\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":34,"alternative-id":["10.3389\/fmed.2026.1725076"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1725076","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,10]]},"article-number":"1725076"}}